Edition:
India

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

346.00SEK
6:56pm IST
Change (% chg)

12.00kr (+3.59%)
Prev Close
334.00kr
Open
359.00kr
Day's High
359.00kr
Day's Low
341.00kr
Volume
8,316
Avg. Vol
3,381
52-wk High
450.40kr
52-wk Low
308.00kr

Summary

Name Age Since Current Position

Jean-Yves Parisot

54 2015 Chairman of the Board

Tom Ronnlund

45 2018 Chief Executive Officer

Henrik Lundkvist

2019 Chief Financial Officer

Niklas Brandt

59 2017 Chief Information Officer and Investor Relations

Niklas Bjarum

55 2017 Vice President America, President of Probi USA Inc.

Linda Neckmar

45 2017 Vice President EMEA and APAC

Jorn Andreas

38 2019 Director

Irene Corthesy Malnoe

60 2018 Independent Director

Charlotte Hansson

56 2017 Independent Director

Jonny Olsson

54 2015 Independent Director

Biographies

Name Description

Jean-Yves Parisot

Dr. Jean-Yves Parisot has been Chairman of the Board of Probi Aktiebolag since April 23, 2015. He holds Master of Business Administration degree and Doctor in Veterinary Medicine degree. He is President of Diana, part of Symrise Group. He is also Chairman of the Board of VetAgroSup. He previously held senior positions at Air Liquide, Danisco, Rhodia Food, Rhone-Poulenc, Merial and Pfizer.

Tom Ronnlund

Mr. Tom Ronnlund has been appointed Chief Executive Officer of PROBI Aktiebolag effective as of the end of 2018 (December 31, 2018). Tom has more than 20 years’ experience working in sales, marketing and general management positions in the healthcare industry. He has recently served as CEO for Norwegian listed company Navamedic ASA. Tom joined Navamedic ASA in 2015 as CEO. Prior to joining Navamedic ASA, Tom Ronnlund has held several positions in sales, marketing and general management at IQVIA (formerly IMS Health) and in international biopharmaceutical companies such as Bristol-Myers Squibb and Eli Lilly. Tom holds a master’s degree in business administration and Economics from Stockholm University.

Henrik Lundkvist

Mr. Henrik Lundkvist is appointed Chief Financial Officer of Probi AB as of Jan 7, 2019, at the latest.

Niklas Brandt

Mr. Niklas Brandt has been Chief Information Officer and Investor Relations at Probi AB since March 1, 2017. He has previously been Chief Financial Officer of the Company since May 2008. He previously worked for six years as Chief Financial Officer of Moving AB. Before that, he had a number of senior positions within finance and administration in a number of companies, such as Tibnor and EF Education. He holds a degree in Business Administration from Lunds Universitet.

Niklas Bjarum

Mr. Niklas Bjarum has been Vice President America at Probi AB since 2017 and he is also President of Probi USA Inc. within the Company. He previously was Vice President of Marketing and Sales at Probi AB from February 2001 till 2017. After receiving hid degree in 1988, he served in a number of positions in sales, marketing and business development of both strategic and operative character in Nestle and Masterfoods (Mars Inc). In 1998, he changed sector and worked three years at Ericsson Mobile Communications with responsibility for business development in Europe. He holds a degree in International Business Administration from Lunds Universitet.

Linda Neckmar

Ms. Linda Neckmar has been Vice President EMEA and APAC at Probi AB since 2017. She has previously been Vice President of Operations at Probi AB since January 2016. She holds Master of Science in Chemical Engineering from Lund University. Linda Neckmar has experience from the biotechnology industry, in pharmaceutical development and international business development, marketing and sales. Linda was employed at Probi in 2011 with responsibility for Marketing and Sales Consumer Healthcare. Prior to this, she worked at BioInvent International AB and OxiGene Inc.

Jorn Andreas

Mr. Jorn Andreas has been Director of Probi AB since May 7, 2019. He no longer serves as Chief Financial Officer of Probi AB, effective as of around December 31, 2018. He has held the position since March 1, 2017. He was Member of the Board of Directors of the Company from April 29, 2014 until March 1, 2017. He has previously been Chief Integration Officer and Vice President, Finance, Symrise Aroma Molecules Division, Jacksonville, the United States. He formerly worked with The Boston Consulting Group, Hamburg, Germany and Bayer AG, Leverkusen, Germany. He holds a Doctorate in Philosophy in Economics from Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Irene Corthesy Malnoe

Ms. Irene Corthesy Malnoe has been Independent Director at PROBI Aktiebolag since May 2, 2018. She runs an independent business as senior consultant within Life Science. She has more than 25 years’ experience of research and development within biotechnology, health, food and beverages. She has previously held senior R&D positions within the Nestle Group and at Lausanne University Hospital. She holds Ph.D. in Molecular Biology from University of Lausanne.

Charlotte Hansson

Ms. Charlotte G. Hansson has been Independent Director at PROBI Aktiebolag since May 4, 2017. She is CEO of MorgonTidig Distribution KB. She previously held senior positions at Jetpak Group AB, Danzas ASG Eurocargo AB and Carl Zeiss AB. She is Board Member of Orio AB, DistIT AB, BE Group AB and Momentum Group AB. She is Candidate of Sciences in Biochemistry from Koebenhavns universitet and studied Market& Economics at IHM.

Jonny Olsson

Mr. Jonny Olsson has been Independent Director of PROBI Aktiebolag since April 23, 2015. He holds Master of Business Administration degree. He is Owner and CEO of Jonny Olsson Consulting AB. He previously held senior positions at Tetra Pak, Oriflame and Ericsson. He is Board Member of The Incredible Journey AB, NGI Denmark, Liquid Consulting Inc & AB.

Basic Compensation